title: [Treatment for invasiveness aspergillosis--recommendations of professionals].
abstract: An increasing incidence of invasive aspergillosis is observed in most immunocompromised patients, and especially patients with acute leukemia and after hematopoietic stem cell transplantation. In order to decrease the mortality due to this infection, the clinicians need to optimise their treatment choice. The objective of these guidelines is to summarize the current evidence for treatment of invasive aspergillosis. The recommendations have been developed by an expert panel following an evidence-based search of literature with regard to current recommendation of European Conference in Infections in Leukemia and Infectious Diseases Society of America.
authors.affiliation: Interní hematoonkologická klinika Lékarské fakulty MU a FN Brno. zracil@fnbrno.cz
authors.forename: Z
authors.initials: Z
authors.lastname: Rácil
authors.forename: J
authors.initials: J
authors.lastname: Mayer
authors.forename: I
authors.initials: I
authors.lastname: Kocmanová
authors.forename: J
authors.initials: J
authors.lastname: Haber
authors.forename: N
authors.initials: N
authors.lastname: Mallátová
authors.forename: M
authors.initials: M
authors.lastname: Kouba
authors.forename: P
authors.initials: P
authors.lastname: Sedlácek
authors.forename: E
authors.initials: E
authors.lastname: Faber
authors.forename: I
authors.initials: I
authors.lastname: Herold
authors.forename: P
authors.initials: P
authors.lastname: Múdry
authors.forename: L
authors.initials: L
authors.lastname: Drgona
authors.forename: M
authors.initials: M
authors.lastname: Karas
authors.forename: V
authors.initials: V
authors.lastname: Buchta
authors.forename: J
authors.initials: J
authors.lastname: Vydra
authors.forename: M
authors.initials: M
authors.lastname: Kolár
authors.forename: J
authors.initials: J
authors.lastname: Trupl
authors.forename: V
authors.initials: V
authors.lastname: Maresová
authors.forename: H
authors.initials: H
authors.lastname: Rozsypal
authors.forename: O
authors.initials: O
authors.lastname: Nýc
authors.forename: K
authors.initials: K
authors.lastname: Cwiertka
mesh_terms: D001228:Aspergillosis / Q000188:drug therapy*; D006801:Humans; D016867:Immunocompromised Host